Ribnikar, D.; Stukalin, I.; Bedard, P.L.; Hamilton, R.J.; Jewett, M.; Warde, P.; Chung, P.; Anson-Cartwright, L.; Templeton, A.J.; Amir, E.;
et al. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer. Curr. Oncol. 2021, 28, 107-114.
https://doi.org/10.3390/curroncol28010014
AMA Style
Ribnikar D, Stukalin I, Bedard PL, Hamilton RJ, Jewett M, Warde P, Chung P, Anson-Cartwright L, Templeton AJ, Amir E,
et al. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer. Current Oncology. 2021; 28(1):107-114.
https://doi.org/10.3390/curroncol28010014
Chicago/Turabian Style
Ribnikar, Domen, Igor Stukalin, Philippe L. Bedard, Robert J. Hamilton, Michael Jewett, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Arnoud J. Templeton, Eitan Amir,
and et al. 2021. "The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer" Current Oncology 28, no. 1: 107-114.
https://doi.org/10.3390/curroncol28010014
APA Style
Ribnikar, D., Stukalin, I., Bedard, P. L., Hamilton, R. J., Jewett, M., Warde, P., Chung, P., Anson-Cartwright, L., Templeton, A. J., Amir, E., Hansen, A. R., Heng, D. Y. C., & Lewin, J.
(2021). The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer. Current Oncology, 28(1), 107-114.
https://doi.org/10.3390/curroncol28010014